BE861265A - Nouveau vaccin antipoliomyelitique stabilise et sa composition stabilisante - Google Patents

Nouveau vaccin antipoliomyelitique stabilise et sa composition stabilisante

Info

Publication number
BE861265A
BE861265A BE182976A BE182976A BE861265A BE 861265 A BE861265 A BE 861265A BE 182976 A BE182976 A BE 182976A BE 182976 A BE182976 A BE 182976A BE 861265 A BE861265 A BE 861265A
Authority
BE
Belgium
Prior art keywords
stabilizing composition
poliomyelitis vaccine
new stabilized
stabilized
new
Prior art date
Application number
BE182976A
Other languages
English (en)
Original Assignee
Connaught Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Connaught Lab filed Critical Connaught Lab
Publication of BE861265A publication Critical patent/BE861265A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/13—Poliovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
BE182976A 1976-11-29 1977-11-28 Nouveau vaccin antipoliomyelitique stabilise et sa composition stabilisante BE861265A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA266,768A CA1067406A (fr) 1976-11-29 1976-11-29 Vaccin oral contre la poliomyelite et milieu stabilisant

Publications (1)

Publication Number Publication Date
BE861265A true BE861265A (fr) 1978-03-16

Family

ID=4107389

Family Applications (1)

Application Number Title Priority Date Filing Date
BE182976A BE861265A (fr) 1976-11-29 1977-11-28 Nouveau vaccin antipoliomyelitique stabilise et sa composition stabilisante

Country Status (10)

Country Link
AT (1) AT351161B (fr)
BE (1) BE861265A (fr)
CA (1) CA1067406A (fr)
DE (2) DE2747662A1 (fr)
DK (1) DK145175C (fr)
FI (1) FI57534C (fr)
FR (1) FR2371927A1 (fr)
NL (1) NL7713087A (fr)
NO (1) NO773378L (fr)
SE (1) SE426440B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4252792A (en) 1979-09-21 1981-02-24 Douglas Industries, Inc. Injectable rabies vaccine composition and method for preparing same
DE3070388D1 (en) * 1980-10-02 1985-05-02 Schering Corp Injectable rabies vaccine composition and method for preparing same
NL8102740A (nl) * 1981-06-05 1983-01-03 Nederlanden Staat Virusvaccins en werkwijze ter bereiding daarvan.
US5360736A (en) * 1992-06-04 1994-11-01 Merck & Co., Inc. Process for attenuated varicella zoster virus vaccine production

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE665076A (fr) * 1963-12-23 1965-12-08

Also Published As

Publication number Publication date
NO773378L (no) 1978-05-30
FR2371927A1 (en) 1978-06-23
FI773015A (fi) 1978-05-30
DE2752725A1 (de) 1978-06-15
CA1067406A (fr) 1979-12-04
SE7712473L (sv) 1978-05-30
FI57534B (fi) 1980-05-30
DK145175B (da) 1982-09-27
DK526477A (da) 1978-05-30
SE426440B (sv) 1983-01-24
DE2747662A1 (de) 1978-06-01
FI57534C (fi) 1980-09-10
DK145175C (da) 1983-02-28
NL7713087A (nl) 1978-05-31
DE2752725C2 (de) 1987-02-12
ATA850077A (de) 1978-12-15
AT351161B (de) 1979-07-10
FR2371927B1 (fr) 1981-06-19

Similar Documents

Publication Publication Date Title
SE7509034L (sv) Borrstabilisator och sett att astadkomma borrstabilisering
DK455880A (da) Stabiliseret vaccine og vaccinestabilisator
NL7803036A (nl) 4-(5-fluormethyl-2-pyridyloxy)fenoxyalkaan- carbonzuren en derivaten daarvan.
FR2316201A1 (fr) Similigranite et sa preparation
LU90037I2 (fr) Konakion et ses dérivés pharmaceutiquement acceptables
FR2315904A1 (fr) Bas therapeutique
FR2285859A1 (fr) Phenylsulfinyl-amidines et derives
DK676274A (da) Kapselemne med oprivningsflig og oprivningsanvisning
SE7505482L (sv) Benso(b)tiofenderivat och sett for framstellning derav
FR2315947A1 (fr) Vaccin contre l'hepatite b
JPS52125175A (en) Piperidyl ester and stabilizing composition containing same
SE7702917L (sv) Stabilisering av erytrocyter
BE863368A (fr) Nouveau vaccin
SE7708265L (sv) Ny farmaceutisk komposition och forfarande for dess framstellning
BE861265A (fr) Nouveau vaccin antipoliomyelitique stabilise et sa composition stabilisante
BE834527A (fr) Perchlorethyle stabilise
PL200968A1 (pl) Ubijak masy dentystycznej i sposob wytwarzania ubijaka masy dentystycznej
BE859277A (fr) Solution injectable de l-pyroglutamyl-l-histidyl-l-prolinamide et sa preparation
DK214577A (da) Benzensulfonylurinstoffer deres fremstilling og anvendelse
JPS52131583A (en) Piperidine derivative and stabilizing composition containing same
DK245075A (da) (d1)-13-substitueret-sulfinyl-prostaglandinlignende forbindelser og fremgangsmade til fremstilling heraf
BE827157A (fr) Vaccin contre la rhinotracheite feline et sa production
DK487375A (da) 5,7-dihydroxytetrahydroisoquinolinderivater og fremgangsmade til fremstilling deraf
NZ186158A (en) Disubstituted piperazine derivatives and pharmaceutical compositions
BE861648A (fr) Compositions et procedes pharmaceutiques

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: CONNAUGHT LABORATORIES LTD

Effective date: 19921130